Nuvasive Inc (NUVA) SEC Filing 8-K Material Event for the period ending Friday, March 23, 2018

Nuvasive Inc

CIK: 1142596 Ticker: NUVA

View differences made from one to another to evaluate Nuvasive Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nuvasive Inc.


Assess how Nuvasive Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nuvasive Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: NUVA
CIK: 1142596
Form Type: 8-K Corporate News
Accession Number: 0001193125-18-094933
Submitted to the SEC: Mon Mar 26 2018 6:32:35 AM EST
Accepted by the SEC: Mon Mar 26 2018
Period: Friday, March 23, 2018
Industry: Surgical And Medical Instruments And Apparatus
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: